Further Information:
The Health Products Regulatory Authority has been notified of a shortage of the following products:
- Augmentin 875mg/125mg Film Coated Tablets - PA1077/019/005
- Bisolvon 4mg/5ml Oral Solution - PA23180/015/001
- Caverject 10mcg Powder and Solvent for Solution for Injection - PA0822/115/002
- Dalmane 30mg Hard Capsules - PA2010/039/002
- Dermovate 0.05% w/w Cream - PA1077/005/001
- Dermovate 0.05%w/w Ointment - PA1077/005/002
- Genotropin MiniQuick 0.6 mg Powder and Solvent for Solution for Injection - PA0822/128/005
- Klacid IV 500mg Powder for Concentrate for Solution for Infusion - PA2010/004/003
- Lercanidipine Clonmel 10mg Film Coated Tablets - PA0126/187/001
- Lercanidipine Clonmel 20mg Film Coated Tablets - PA0126/187/002
- Lopid 300mg Capsules - PA0822/014/001
- Minims Chloramphenicol 0.5% Eye Drops - PA22698/006/001
- Opticrom allergy 2% w/v Eye Drops - PA23180/010/002
- OxyContin 10mg Prolonged Release Tablets - PA1688/005/002
- Parnate 10mg Tablet - PA1142/035/001
- Pazenir 5mg/ml Powder for Dispersion for Infusion - EU/1/18/1317/001
- Solpadeine Capsules (32 pack) - PA1186/011/002
- Solpadeine Soluble Tablets (12 and 60 pack) - PA1186/011/001
- Tamoxifen 20mg Tablets - PA0577/207/001
- Zirtek 10mg Film Coated tablets - PA0891/008/002
The following shortages have been resolved and supply has resumed to the Irish market:
- Adrenaline (Epinephrine) 1:1,000 Solution for Injection - PA0073/035/001
- Dalacin T Topical Lotion 10mg/ml Cutaneous Emulsion - PA0822/121/001
- Dioralyte Blackcurrant Powder for Oral Solution - PA23180/006/001
- Fungizone 50mg Powder for sterile concentrate - PA2239/004/001
- Fydrane 0.2mg/ml + 3.1mg/ml + 10mg/ml, Solution for Injection - PA1107/012/001
- Navelbine 30mg Soft Capsules - PA0329/011/002
- Ondansetron 2mg/ml Solution for Injection (4ml presentation) - PA1122/004/001
- Ozempic 0.5mg Solution for injection - EU/1/17/1251/003
- Quofenix Tabs 450mg - EU/1/19/1393/002
- Roactemra 162mg Pre-filled Pen - EU/1/08/492/009
- Vimpat 10mg/ml Syrup - EU/1/08/470/018
- Yasmin 0.03mg/3mg Film-Coated Tablets - PA1410/023/001
Please see the shortages section of the HPRA website for further information
The HPRA sends weekly updates concerning medicinal product shortages. However, the above webpage will be updated as new information is provided to the HPRA.